Tacrolimus capsules is an immunosuppressant. It blocks the action of certain blood cells (eg, T lymphocytes) that can cause the body to reject the transplanted organ.
Mylan Pharma’s Tacrolimus capsules, 0.5mg, 1mg and 5mg is the generic version of Astellas’ Prograf capsules, a treatment to prevent rejection in people who have received certain organ transplants.
The company intends to introduce the drug immediately.